Early PAH Detection: Novel PET Scan
- A novel molecular imaging approach, known as 18F-FAPI PET, offers a potential breakthrough in the early detection of pulmonary arterial hypertension (PAH).
- Pulmonary arterial hypertension is a severe, progressive condition characterized by abnormally high blood pressure in the arteries connecting the heart and lungs.
- Cheng Hong, a pulmonary vascular medicine specialist in Guangzhou, China, noted that fibroblasts activate during the remodeling process.
Detect early signs of pulmonary arterial hypertension (PAH) with a groundbreaking molecular imaging approach: 18F-FAPI PET. This novel technique identifies tissue remodeling,providing a crucial early marker for disease progression,and paving teh way for more effective,personalized treatments. Experts believe this early detection capability can truly transform patient outcomes. unlike customary methods, 18F-FAPI PET offers a view into the earliest stages of PAH, possibly allowing for timely interventions before irreversible damage occurs. The study, which News Directory 3 covered extensively, also revealed that this innovative imaging helps to monitor the effectiveness of PAH-targeted therapies, offering a new tool for personalized medicine. Discover what’s next as researchers explore 18F-FAPI PET imaging’s long-term benefits.
New Imaging Technique Detects Early Signs of Pulmonary Hypertension
Updated June 13, 2025
A novel molecular imaging approach, known as 18F-FAPI PET, offers a potential breakthrough in the early detection of pulmonary arterial hypertension (PAH). The technique identifies initial signs of tissue remodeling, providing doctors with a crucial early marker of disease progression. Experts believe this coudl lead to more tailored and timely interventions, ultimately improving patient outcomes in managing pulmonary arterial hypertension.
Pulmonary arterial hypertension is a severe, progressive condition characterized by abnormally high blood pressure in the arteries connecting the heart and lungs. This elevated pressure often stems from structural changes, such as narrowing or damage to the arteries due to tissue remodeling.
Dr. Cheng Hong, a pulmonary vascular medicine specialist in Guangzhou, China, noted that fibroblasts activate during the remodeling process. Hong said that while traditional PAH assessments rely on hemodynamic measurements and echocardiography, their team explored whether imaging fibroblast activation protein could predict PAH progression.
The research involved both animal and human models.In the animal study, 15 rats with induced PAH and five control rats underwent 18F-FAPI PET imaging and hemodynamic measurements on days seven, 14, and 21. Researchers then compared changes in 18F-FAPI uptake with hemodynamic shifts.
The human study included 38 PAH patients who underwent 18F-FAPI PET imaging, along with right heart catheterization and echocardiography within a week to evaluate pulmonary hemodynamics and cardiac function. The team also assessed treatment response in patients receiving PAH-targeted therapy.
The study revealed a correlation between increased 18F-FAPI uptake in the right side of the heart and pulmonary arteries and both hemodynamics and cardiac function. Among five patients receiving PAH-targeted treatment, three showed reduced 18F-FAPI uptake after a second scan, aligning with clinical improvements.
Dr. Xinlu Wang, a nuclear medicine specialist also in Guangzhou, China, emphasized the significance of detecting fibroblast activation in PAH patients. Wang said this capability could provide an early indication of disease progression, perhaps before irreversible structural changes occur.
Wang added that the study also found that 18F-FAPI uptake decreased in the right heart and pulmonary artery of patients after PAH-targeted therapy, suggesting that fibroblast activation in PAH may be reversible. Wang believes 18F-FAPI PET could help clinicians monitor the effectiveness of PAH-targeted therapies, offering a new tool for personalized medicine.
What’s next
Further research is planned to explore the long-term benefits of 18F-FAPI PET imaging in managing pulmonary arterial hypertension and refining personalized treatment strategies.
Worth a look
- St. Anthony’s General Hospital visitors may have been exposed to measles
- CBL-514 Injection Reduces Subcutaneous and Visceral Fat in Trial
- MEGATRON Simulation Connects Early Universe Stars with Milky Way Fossils (time.news)
- Why Leaves Are Changing Color Early: What Drought Stress Means (daybreakwire.com)